International Society for Pharmacoepidemiology (ISPE) statement on American Society of Clinical Oncology's new policy for relationships with companies-Reference-Cited by-同舟云学术

International Society for Pharmacoepidemiology (ISPE) statement on American Society of Clinical Oncology's new policy for relationships with companies

Published:2013-11-21 Issue:1 Volume:23 Page:1-2
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Acquavella John¹,Sturmer Til²,Hallas Jesper³

Affiliation:

1. Amgen, Global Epidemiology; Thousand Oaks California United States

2. Deparment of Epidemiology; University of North Carolina at Chapel Hill, School of Public Health; Chapel Hill North Carolina United States

3. Research Unit of Clinical Pharmacology; University of Southern Denmark; Odense Denmark

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference4 articles.

1. American Society of Clinical Oncology policy for relationships with companies: background and rationale;American Society for Clinical Oncology;J Clin Oncol,2013

2. European Network of Centres for Pharmagoepidemiology and Pharmacovigilance Code of conduct http://www.encepp.eu/code_of_conduct/

3. International Committee of Medical Journal Editors Uniform requirements for manuscripts submitted to biomedical journals: ethical considerations in the conduct and reporting of research: authorship and contributorship http://www.icmje.org/ethical_1author.html

4. Guidelines for good pharmacoepidemiologic practices (GPP);Pharmacoepidemiol Drug Saf,2008

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global matters of epidemiology and the ethical challenges of addressing the health of populations;Annals of Epidemiology;2024-03

2. Conflict of interest: a hazard for epidemiology;Annals of Epidemiology;2019-06